主要論文

1. LIGHT regulated gene expression in rheumatoid synovial fibroblasts.
   Fukuda K, Miura Y, Maeda T, Hayashi S, Kikuchi K, Takashima Y, Matsumoto T, Kuroda R.
   Mol Biol Rep. 2024 Feb 24;51(1):356. doi: 10.1007/s11033-024-09311-0. PMID: 38401037
2. A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients.
   Hayashi S, Matsubara T, Fukuda K, Maeda T, Funahashi K, Hashimoto M, Takashima Y, Kikuchi K, Fujita M, Matsumoto T, Kuroda R.
   Rheumatol Adv Pract. 2022 Oct 29;6(3):rkac088. doi: 10.1093/rap/rkac088. eCollection 2022. PMID: 36382269
3. Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment.
   Hayashi S, Matsubara T, Maeda T, Fukuda K, Funahashi K, Hashimoto M, Tsumiyama K, Kamenaga T, Takashima Y, Matsumoto T, Tachibana S, Kuroda R.
   Sci Rep. 2022 Oct 20;12(1):17524. doi: 10.1038/s41598-022-22152-w. PMID: 36266430
4. Polyarthritis presented in a patient with untreated chronic hepatitis B infection.
   Kikuchi K, Fukuda K, Hayashi S, Maeda T, Takashima Y, Fujita M, Ikuta K, Anjiki K, Tachibana S, Onoi Y, Matsumoto T, Kuroda R, Matsubara T.
   Mod Rheumatol Case Rep. 2023 Jan 3;7(1):320-323. doi: 10.1093/mrcr/rxac075. PMID: 36214605
5. Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching.
   Nozaki Y, Oribe M, Tomita D, Itami T, Hayashi S, Maeda T, Fukuda K, Kuroda R, Funahashi K, Matsubara T, Kinoshita K, Matsumura I.
   Mod Rheumatol. 2023 Apr 13;33(3):472-480. doi: 10.1093/mr/roac060. PMID: 35695707
6. Histopathological changes of synovial tissue in rheumatoid arthritis patients treated with TNF-α inhibitors or IL-6 inhibitors.
   Takashima Y, Hayashi S, Maeda T, Fukuda K, Onoi Y, Tachibana S, Ikuta K, Anjiki K, Fujita M, Kikuchi K, Kamenaga T, Kuroda R, Matsubara T.
   Clin Exp Rheumatol. 2022 Nov;40(11):2060-2070. doi: 10.55563/clinexprheumatol/2qc1am. Epub 2022 Jan 25. PMID: 35084317 
7. Expression profiling of genes in rheumatoid fibroblast-like synoviocytes regulated by Fas ligand via cDNA microarray analysis.
   Fukuda K, Miura Y, Maeda T, Hayashi S, Matsumoto T, Kuroda R.
   Exp Ther Med. 2021 Sep;22(3):1000. doi: 10.3892/etm.2021.10432. Epub 2021 Jul 15. PMID: 34345282
8. Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.
   Takashima Y, Hayashi S, Fukuda K, Maeda T, Tsubosaka M, Kamenaga T, Kikuchi K, Fujita M, Kuroda Y, Hashimoto S, Nakano N, Matsumoto T, Kuroda R.
   Sci Rep. 2021 Jun 15;11(1):12516. doi: 10.1038/s41598-021-92055-9. PMID: 34131243
9. A genome-wide association study identifying the SNPs predictive of rapid joint destruction in patients with rheumatoid arthritis.
   Hayashi S, Matsubara T, Fukuda K, Maeda T, Funahashi K, Hashimoto M, Kamenaga T, Takashima Y, Kuroda R.
   Biomed Rep. 2021 Mar;14(3):31. doi: 10.3892/br.2021.1407. Epub 2021 Jan 29. PMID: 33585033
10. Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis.
    Hayashi S, Matsubara T, Fukuda K, Funahashi K, Hashimoto M, Maeda T, Kamenaga T, Takashima Y, Matsumoto T, Niikura T, Kuroda R.
    Sci Rep. 2020 Oct 6;10(1):16645. doi: 10.1038/s41598-020-73968-3. PMID: 33024253
11. Gelatin hydrogels with eicosapentaenoic acid can prevent osteoarthritis progression in vivo in a mouse model.
    Tsubosaka M, Kihara S, Hayashi S, Nagata J, Kuwahara T, Fujita M, Kikuchi K, Takashima Y, Kamenaga T, Kuroda Y, Takeuchi K, Fukuda K, Takayama K, Hashimoto S, Matsumoto T, Niikura T, Tabata Y, Kuroda R.
    J Orthop Res. 2020 Oct;38(10):2157-2169. doi: 10.1002/jor.24688. Epub 2020 Apr 15. PMID: 32270890
12. Sciatic Nerve Palsy following Curved Periacetabular Osteotomy.
    Fujita M, Hayashi S, Kikuchi K, Takashima Y, Kamenaga T, Tsubosaka M, Fukuda K, Takayama K, Hashimoto S, Niikura T, Kuroda R, Matsumoto T.
    Case Rep Orthop. 2020 Mar 19;2020:8569285. doi: 10.1155/2020/8569285. eCollection 2020. PMID: 32257486
13. Pelvic morphology medial to the femoral head center predicts anterior coverage and range of motion after curved periacetabular osteotomy.
    Kamenaga T, Hayashi S, Hashimoto S, Fukuda K, Takayama K, Tsubosaka M, Takashima Y, Niikura T, Kuroda R, Matsumoto T.
    J Orthop Res. 2020 Sep;38(9):2031-2039. doi: 10.1002/jor.24624. Epub 2020 Feb 17. PMID: 32034795
14. Denosumab Treatment Improved Health-Related Quality of Life in Osteoporosis: A Prospective Cohort Study.
    Hayashi S, Fukuda K, Maeda T, Chinzei N, Kihara S, Miura Y, Sakai Y, Hashimoto S, Matsumoto T, Takayama K, Niikura T, Kuroda R.
    JBMR Plus. 2019 May 7;3(7):e10191. doi: 10.1002/jbm4.10191. eCollection 2019 Jul. PMID: 31372593
15. Expression profiling of genes in rheumatoid fibroblast-like synoviocytes regulated by tumor necrosis factor-like ligand 1A using cDNA microarray analysis.
    Fukuda K, Miura Y, Maeda T, Hayashi S, Kuroda R.
    Biomed Rep. 2019 Jul;1(1):1-5. doi: 10.3892/br.2019.1216. Epub 2019 May 22. PMID: 31258900
16. Decoy receptor 3 down-regulates centrosomal protein 70 kDa specifically in rheumatoid synovial fibroblasts.
    Fukuda K, Miura Y, Maeda T, Hayashi S, Kuroda R.
    Mod Rheumatol. 2018 Mar;28(2):287-292. doi: 10.1080/14397595.2017.1341593. Epub 2017 Jul 11. PMID: 28696795
17. Interleukin12B is upregulated by decoy receptor 3 in rheumatoid synovial fibroblasts.
    Fukuda K, Miura Y, Maeda T, Hayashi S, Kurosaka M.
    Mol Med Rep. 2016 Apr;13(4):3647-52. doi: 10.3892/mmr.2016.4985. Epub 2016 Mar 7. PMID: 26956410
18. Decoy receptor 3 regulates the expression of tryptophan hydroxylase 1 in rheumatoid synovial fibroblasts.
    Maeda T, Miura Y, Fukuda K, Hayashi S, Kurosaka M.
    Mol Med Rep. 2015 Oct;12(4):5191-6. doi: 10.3892/mmr.2015.4097. Epub 2015 Jul 20. PMID: 26238767
19. Gastroesophageal reflux disease in patients with rheumatoid arthritis.
    Miura Y, Fukuda K, Maeda T, Kurosaka M.
    Mod Rheumatol. 2014 Mar;24(2):291-5. doi: 10.3109/14397595.2013.843749. Epub 2013 Nov 5. PMID: 24252041
20. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K, Miura Y, Maeda T, Takahashi M, Hayashi S, Kurosaka M.
    Int J Mol Med. 2013 Oct;32(4):910-6. doi: 10.3892/ijmm.2013.1461. Epub 2013 Aug 1. PMID: 23912906
21. Neurogenic bladder associated with pure cervical spondylotic myelopathy: clinical characteristics and recovery after surgery.
    Fukuda K, Ozaki T, Tsumura N, Sengoku A, Nomi M, Yanagiuchi A, Nishida K, Kuroda R, Iguchi T.
    Spine (Phila Pa 1976). 2013 Jan 15;38(2):104-11. doi: 10.1097/BRS.0b013e318267af02. PMID: 22781004
22. Indications and limitations of conservative treatment for pyogenic spondylitis.
    Fukuda K, Miyamoto H, Uno K, Okada Y.
    J Spinal Disord Tech. 2014 Aug;27(6):316-20. doi: 10.1097/BSD.0b013e31825d6aca. PMID: 22614267
23. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
    Takahashi M, Miura Y, Hayashi S, Tateishi K, Fukuda K, Kurosaka M.
    Int J Mol Med. 2011 Sep;28(3):423-7. doi: 10.3892/ijmm.2011.687. Epub 2011 May 2. PMID: 21537832
24. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty.
    Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, Kubo S, Matsumoto T, Matsushita T, Chin T, Iguchi T, Kurosaka M, Kuroda R.
    Int Orthop. 2011 Nov;35(11):1639-45. doi: 10.1007/s00264-010-1205-3. Epub 2011 Jan 21. PMID: 21253725
25. Stress fracture of the second metacarpal bone in a badminton player.
    Fukuda K, Fujioka H, Fujita I, Uemoto H, Hiranaka T, Tsuji M, Kurosaka M.
    Kobe J Med Sci. 2008 Jul 18;54(3):E159-62. PMID: 19246963